News

Researchers have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

The researchers believe the discovery of this mechanism adds another piece to the puzzle in the ongoing effort to uncover the mysteries of memory.

An action-oriented scientific agenda for tackling global climate change and its impacts on agriculture emerged from the international, three-day Climate-Smart Agriculture Conference.

New research from UC Davis shows that blocking an enzyme that promotes inflammation can prevent the tissue damage following a heart attack that often leads to heart failure.

A new study of genetically modified immune cells by scientists from UCLA and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.

For the first time, the complete genomes of three separate populations of aye-ayes have been sequenced and analyzed in an effort to help guide conservation efforts.

Picower Institute neuroscientists use single dose of experimental drug; could prove promising for treatment of autism symptoms.

Parched land in China has prompted Cornell environmental experts to come up with a simple solution to restore soils in arid areas, using wood chips and compost.

CHOP/Penn Medicine oncology team reports complete remission in pediatric ALL patients.

Dr Ivan Cohen-Tanugi, with over 20 years’ experience in the international pharmaceutical industry, will prepare Eyevensys to launch clinical trials for the company’s non-viral gene therapy processes in two ophthalmic indications.